Search research articles
Contact Us
Filters
Showing results (251-260 of 274) with videos related to
Page
of 28
Sort By:
The Journal of Clinical Investigation
|
June 5, 2018
Neuronatin regulates pancreatic β cell insulin content and secretion
Steven J Millership, Gabriela Da Silva Xavier, Agharul I Choudhury, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2025
GLP-1R associates with VAPB and SPHKAP at ERMCSs to regulate β-cell mitochondrial remodelling and function
Gregory Austin, Affiong I Oqua, Liliane El Eid, et al.
The Journal of Clinical Investigation
|
April 21, 2005
The role of insulin receptor substrate 2 in hypothalamic and beta cell function
Agharul I Choudhury, Helen Heffron, Mark A Smith, et al.
Biorxiv : the Preprint Server for Biology
|
November 1, 2024
<i>In vivo</i> functional profiling and structural characterisation of the human <i>Glp1r</i> A316T variant
Liliane El Eid, Kieran Deane-Alder, Roxana-Maria Rujan, et al.
Diabetes
|
January 27, 2011
Deletion of Lkb1 in pro-opiomelanocortin neurons impairs peripheral glucose homeostasis in mice
Marc Claret, Mark A Smith, Claude Knauf, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 10, 2025
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Adults and Adolescents with Cystic Fibrosis and at Least One <i>F508del</i> Allele: A Phase 3, Open-Label Extension Study
Cori L Daines, Deepika Polineni, Elizabeth Tullis, et al.
Science (New York, N.Y.)
|
October 3, 2009
Ribosomal protein S6 kinase 1 signaling regulates mammalian life span
Colin Selman, Jennifer M A Tullet, Daniela Wieser, et al.
Nature Metabolism
|
December 5, 2019
Cardiac glycosides are broad-spectrum senolytics
Ana Guerrero, Nicolás Herranz, Bin Sun, et al.
The European Respiratory Journal
|
November 9, 2023
Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one <i>F508del</i> allele: 144-week interim results from a 192-week open-label extension study
Cori L Daines, Elizabeth Tullis, Stefano Costa, et al.
BMJ Open
|
August 11, 2019
Testing a support programme for opioid reduction for people with chronic non-malignant pain: the I-WOTCH randomised controlled trial protocol
Harbinder K Sandhu, Charles Abraham, Sharisse Alleyne, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 274) with videos related to
Sort By:
Page
of 28
The Journal of Clinical Investigation
|
June 5, 2018
Neuronatin regulates pancreatic β cell insulin content and secretion
Steven J Millership, Gabriela Da Silva Xavier, Agharul I Choudhury, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2025
GLP-1R associates with VAPB and SPHKAP at ERMCSs to regulate β-cell mitochondrial remodelling and function
Gregory Austin, Affiong I Oqua, Liliane El Eid, et al.
The Journal of Clinical Investigation
|
April 21, 2005
The role of insulin receptor substrate 2 in hypothalamic and beta cell function
Agharul I Choudhury, Helen Heffron, Mark A Smith, et al.
Biorxiv : the Preprint Server for Biology
|
November 1, 2024
<i>In vivo</i> functional profiling and structural characterisation of the human <i>Glp1r</i> A316T variant
Liliane El Eid, Kieran Deane-Alder, Roxana-Maria Rujan, et al.
Diabetes
|
January 27, 2011
Deletion of Lkb1 in pro-opiomelanocortin neurons impairs peripheral glucose homeostasis in mice
Marc Claret, Mark A Smith, Claude Knauf, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 10, 2025
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Adults and Adolescents with Cystic Fibrosis and at Least One <i>F508del</i> Allele: A Phase 3, Open-Label Extension Study
Cori L Daines, Deepika Polineni, Elizabeth Tullis, et al.
Science (New York, N.Y.)
|
October 3, 2009
Ribosomal protein S6 kinase 1 signaling regulates mammalian life span
Colin Selman, Jennifer M A Tullet, Daniela Wieser, et al.
Nature Metabolism
|
December 5, 2019
Cardiac glycosides are broad-spectrum senolytics
Ana Guerrero, Nicolás Herranz, Bin Sun, et al.
The European Respiratory Journal
|
November 9, 2023
Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one <i>F508del</i> allele: 144-week interim results from a 192-week open-label extension study
Cori L Daines, Elizabeth Tullis, Stefano Costa, et al.
BMJ Open
|
August 11, 2019
Testing a support programme for opioid reduction for people with chronic non-malignant pain: the I-WOTCH randomised controlled trial protocol
Harbinder K Sandhu, Charles Abraham, Sharisse Alleyne, et al.
Page
of 28